SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

NCT00006003 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

35

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Recurrent Melanoma
Stage IV Melanoma

Interventions

DRUG: semaxanib
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)